Market research
EXP.V Experion Holdings Ltd
V CAD Healthcare
Latest close
As of 05 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 40M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.98
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA17291F1080
- Market cap
- 40M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.98
About
About Experion Holdings Ltd
Citizen Stash Cannabis Corp., through its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada. Its products are used for adult-use, wellness and therapeutic, and medical applications. Experion Holdings Ltd. offers its products under the Citizen Stash and Kanabe brand names. The company was formerly known as Experion Holdings Ltd. and changed its name to Citizen Stash Cannabis Corp. in June 2021. Citizen Stash Cannabis Corp. is headquartered in Mission, Canada.
Research context
Experion Holdings Ltd appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the EXP.V discussion.
5 years, 6 months ago
Experion Holdings Ltd is currently in a long term uptrend where the price is trading 38.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Experion Holdings Ltd's total revenue rose by 235.5% to $2M since the same quarter in the previous year.
Its net income has increased by 98.2% to $-188K since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $-2M since the same quarter in the previous year.
Based on the above factors, Experion Holdings Ltd gets an overall score of 4/5.